Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment "COGICRehab"


Phase 2 Results N/A

Summary of Purpose

The investigators would like to conduct a double blind placebo-controlled prospective study to show the impact of a treatment combining a specific cognitive rehabilitation program and acetylcholinesterase inhibitors on executive function of young patients 3 months after a first symptomatic stroke. The secondary objectives will be to assess cognitive changes performance (executive but also non trained functions...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 February 2012.

1 Jul 2011 1 Jul 2011 1 Jan 2015 1 Jan 2015 1 Jan 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available